menu
    • menu

    Company profile for Affini-T Therapeutics

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We orchestrate the immune system to target oncogenic driver mutations to deliver transformative therapies intended to cure patients. Affini-T’s co-founders have proven expertise in innovation for immune cell therapies, and our experienced management team is committed to advancing breakthrough therapies for patients. Our validated TCR discovery platform leverages synthetic biology and gene editing technologies, allowing our ...
    We orchestrate the immune system to target oncogenic driver mutations to deliver transformative therapies intended to cure patients. Affini-T’s co-founders have proven expertise in innovation for immune cell therapies, and our experienced management team is committed to advancing breakthrough therapies for patients. Our validated TCR discovery platform leverages synthetic biology and gene editing technologies, allowing our team to overcome key hurdles in cellular engineering that have prevented the field from developing therapies for solid tumor cancers in the past.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Affini-T TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    343 Arsenal St. Watertown MA 02472
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://affinittx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/affini-t-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter
    https://mobile.x.com/affinit_tx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Affini-T Therapeutics to Present at Morgan Healthcare Conference
    Affini-T Therapeutics to Present at Morgan Healthcare Conference

    09 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250109838633/en

    BUSINESSWIRE
    09 Jan 2025
    Share Share
    Affini-T to Present Data on Oncogenic Driver Programs at SITC
    Affini-T to Present Data on Oncogenic Driver Programs at SITC

    06 Nov 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241106297988/en

    BUSINESSWIRE
    06 Nov 2024
    Share Share
    Affini-T: First Patient Dosed In KRAS G12V Trial, ASCO 2024 Presentation
    Affini-T: First Patient Dosed In KRAS G12V Trial, ASCO 2024 Presentation

    28 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240528503183/en

    BUSINESSWIRE
    28 May 2024
    Share Share
    Affini-T: KRAS, TP53 Preclinical Data At ASGCT Annual Meeting
    Affini-T: KRAS, TP53 Preclinical Data At ASGCT Annual Meeting

    01 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240501955728/en

    BUSINESSWIRE
    01 May 2024
    Share Share
    Affini-T Presents Preclinical Data at the AACR Annual Meeting 2024
    Affini-T Presents Preclinical Data at the AACR Annual Meeting 2024

    07 Apr 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240407453794/en

    BUSINESSWIRE
    07 Apr 2024
    Share Share
    Affini-T to Present Preclinical Data from its Programs Targeting KRAS G12D
    Affini-T to Present Preclinical Data from its Programs Targeting KRAS G12D

    13 Mar 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240313781856/en

    BUSINESSWIRE
    13 Mar 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search